Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple Self-Swab replace the pap smear? indonesia tests HPV Self-Collection

NCT ID NCT06942286

Diagnosis Sponsor: Dharmais National Cancer Center Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing whether women in Indonesia can successfully collect their own samples for HPV testing, which could make cervical cancer screening more accessible. Researchers will enroll 8,000 women aged 30-69 who haven't been screened recently. The goal is to see if self-collection is a practical and effective way to detect HPV and prevent cervical cancer.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
HPV self-collection kit
What this could lead to
If successful, this could make cervical cancer screening easier and more accessible for women in Indonesia, potentially reducing cancer rates through earlier detection.
What could go wrong
This is a pilot study, so results may not apply to all populations. Self-collection may have lower accuracy than clinician-collected samples, and participation rates could be low.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 8,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 69 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 30-69 years old * Have not had a Pap test within the last 3 years or an HPV test within the last 5 years * Have never been diagnosed with cervical cancer or high-grade dysplasia * Have no history of hysterectomy with cervical removal * Expressed willingness to participate in the study, including conducting HPV self-collection, follow-up treatment, and related surveys Exclusion Criteria: * Being pregnant or within 6 weeks postpartum * Women who have never engaged in sexual activity * Medical, psychiatric, or other conditions that may interfere with compliance with protocols, security assessments, and/or ability/competence to give informed consent * Adults who do not have the capacity to give consent may be excluded, as participants must be able to perform activities required by the protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical cancers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cervical cancer cervical carcinoma cervical intraepithelial neoplasia dysplasia of cervix human papilloma virus infection Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervical cancers Cin - cervical intraepithelial neoplasia Human papillomavirus (HPV)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dharmais National Cancer Center Hospital

    Jakarta, Jakarta Special Capital Region, 11420, Indonesia

  • Puskesmas Depok

    Depok, West Java, Indonesia

  • Puskesmas Lebak

    Lebak, Banten, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.